. Show Affiliations »
Abstract
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedDrug ApprovalHumansMacular Degeneration/drug therapyRanibizumabUnited StatesUnited States Food and Drug Administration
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedRanibizumab
Year: 2006 PMID: 17326303
Source DB: PubMed Journal: FDA Consum ISSN: 0362-1332